Reading MOH? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track MOH free→Reading MOH? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track MOH free→QuarterlyIQ Insights · MOH
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. At the 2026 Annual Meeting of Stockholders (the “Annual Meeting”) of Molina Healthcare, Inc. (the “Company”) held on May 6, 2026, as further described in
Regulation FD Disclosure. As previously announced, Molina Healthcare, Inc. (the “Company”) will host its Investor Day Conference on May 8, 2026, beginning at 9:30 a.m. Eastern Time. At the event, the Company will provide various updates regarding its business, including on its long-term financial targets and strategic and operational plans. A copy of the Investor Day presentation materials is attached hereto as Exhibit 99.1 and incorporated herein by reference. A live webcast of the Company’s…
Results of Operations and Financial Condition. On April 22, 2026, Molina Healthcare, Inc. (the “Company”) issued a press release reporting its financial results for the first quarter ended March 31, 2026 and reaffirming the Company’s full-year 2026 premium revenue and adjusted earnings guidance. The full text of the press release is included as Exhibit 99.1 to this report. The information contained in the Company’s website cited in the press release is not part of this report. Note: The infor…
Regulation FD Disclosure. 2026 Outlook Affirmation Members of the senior management team of Molina Healthcare, Inc. (“Molina” or the “Company”) will be meeting with investors and analysts over the next several days, and on Tuesday, March 3, 2026, will also be participating in TD Cowen’s 46 th Annual Health Care Conference. Consistent with the Company’s guidance previously provided on February 6, 2026, the senior management team plans to reaffirm the Company’s 2026 full year GAAP diluted earni…
Material Impairments On February 5, 2026, the Company concluded that it will record in the first quarter of 2026 an estimated non-cash, pre-tax impairment charge of approximately $93 million, attributable to certain of its intangible assets. This impairment charge results from the Company’s decision to exit the Medicare Advantage Prescription Drug product for 2027 as that product does not align with the Company’s strategic shift to focus exclusively on dual eligible members in Medicare. This…
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth in
Entry into a Material Definitive Agreement. On February 4, 2026, Molina Healthcare, Inc. (the “Company”) entered into a First Amendment to its Credit Agreement (the “Amended Credit Agreement”) among the Company, as the Borrower, the Lenders (as defined therein) party thereto, and Truist Bank, as Administrative Agent. The Amended Credit Agreement amends the Company’s prior Credit Agreement dated as of November 20, 2025 (the “Prior Credit Agreement”). The terms of the Amended Credit Agreement a…
Results of Operations and Financial Condition. On February 5, 2026, Molina Healthcare, Inc. (the “Company”) issued a press release reporting its financial results for the fourth quarter and year ended December 31, 2025 and the Company’s full-year 2026 revenue and earnings guidance. The full text of the press release is included as Exhibit 99.1 to this report. The information contained in the Company’s website cited in the press release is not part of this report. Note: The information in this…
Results of Operations and Financial Condition. On October 22, 2025, Molina Healthcare, Inc. (the “Company”) issued a press release reporting its financial results for the third quarter ended September 30, 2025 and updating the Company’s full-year 2025 earnings guidance. The full text of the press release is included as Exhibit 99.1 to this report. The information contained in the Company’s website cited in the press release is not part of this report. Note: The information in this Form 8-K an…
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.